Citation: | SUN Jichao, ZHANG Bixia, LI Weiwei. Effects of Zishen Xieqing Tang on Dopamine Signaling Pathway of Desensitization/Resensitization in Attention Deficit Hyperactivity Disorder Rats' Prefrontal Cortex[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(12): 1137-1142. doi: 10.14148/j.issn.1672-0482.2022.1137 |
[1] |
POLANCZYK GV, WILLCUTT EG, SALUM GA, et al. ADHD prevalence estimates across three decades: An updated systematic review and meta-regression analysis[J]. Int J Epidemiol, 2014, 43(2): 434-442. doi: 10.1093/ije/dyt261
|
[2] |
SWANSON JM, KINSBOURNE M, NIGG J, et al. Etiologic subtypes of attention-deficit/hyperactivity disorder: Brain imaging, molecular genetic and environmental factors and the dopamine hypothesis[J]. Neuropsychol Rev, 2007, 17(1): 39-59. doi: 10.1007/s11065-007-9019-9
|
[3] |
孙继超, 张碧霞, 朱万青, 等. 滋肾泻青汤联合盐酸托莫西汀治疗儿童注意缺陷多动障碍疗效观察[J]. 广西中医药大学学报, 2021, 24(4): 9-12. https://www.cnki.com.cn/Article/CJFDTOTAL-GSZB202104004.htm
SUN JC, ZHANG BX, ZHU WQ, et al. Clinical observation on treatment of attention deficit hyperactivity disorder by zishen Xieqing Decoction in combination with atomoxetine hydrochloride[J]. J Guangxi Univ Chin Med, 2021, 24(4): 9-12. https://www.cnki.com.cn/Article/CJFDTOTAL-GSZB202104004.htm
|
[4] |
REAGAN-SHAW S, NIHAL M, AHMAD N. Dose translation from animal to human studies revisited[J]. FASEB J, 2008, 22(3): 659-661. doi: 10.1096/fj.07-9574LSF
|
[5] |
袁海霞, 倪新强, 吴正治, 等. 基于"肾脑相关"探讨熟地黄对ADHD模型大鼠行为学的影响[J]. 中药材, 2018, 41(8): 1970-1974. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYCA201808042.htm
YUAN HX, NI XQ, WU ZZ, et al. Impact of Rehmannia glutinosa on behavior of attention deficit hyperactivity disorder(ADHD) model rats based on the correlation of kidney and brain[J]. J Chin Med Mater, 2018, 41(8): 1970-1974. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYCA201808042.htm
|
[6] |
孙继超, 尤月, 周荣易, 等. 安神定志灵对ADHD模型大鼠前额叶、纹状体CDK5/DARPP32/PP1信号通路的影响[J]. 中国实验方剂学杂志, 2016, 22(17): 81-86. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201617018.htm
SUN JC, YOU Y, ZHOU RY, et al. Effects of Anshen dingzhiling compound on signaling pathway of CDK5/DARPP32/PP1 in ADHD rats' Striatum and prefrontal cortex[J]. Chin J Exp Tradit Med Formulae, 2016, 22(17): 81-86. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201617018.htm
|
[7] |
PEREIRA-SANCHEZ V, CASTELLANOS FX. Neuroimaging in attention-deficit/hyperactivity disorder[J]. Curr Opin Psychiatry, 2021, 34(2): 105-111. doi: 10.1097/YCO.0000000000000669
|
[8] |
KLEIN MO, BATTAGELLO DS, CARDOSO AR, et al. Dopamine: Functions, signaling, and association with neurological diseases[J]. Cell Mol Neurobiol, 2019, 39(1): 31-59. doi: 10.1007/s10571-018-0632-3
|
[9] |
VOGT BA. Cingulate impairments in ADHD: Comorbidities, connections, and treatment[J]. Handb Clin Neurol, 2019, 166: 297-314.
|
[10] |
BEAULIEU JM, GAINETDINOV RR. The physiology, signaling, and pharmacology of dopamine receptors[J]. Pharmacol Rev, 2011, 63(1): 182-217. doi: 10.1124/pr.110.002642
|
[11] |
PETRILLO MG, OAKLEY RH, CIDLOWSKI JA. β-Arrestin-1 inhibits glucocorticoid receptor turnover and alters glucocorticoid signaling[J]. J Biol Chem, 2019, 294(29): 11225-11239. doi: 10.1074/jbc.RA118.007150
|
[12] |
MA TL, ZHOU Y, ZHANG CY, et al. The role and mechanism of β-arrestin2 in signal transduction[J]. Life Sci, 2021, 275: 119364. doi: 10.1016/j.lfs.2021.119364
|
[13] |
WANG N, SU P, ZHANG Y, et al. Protein kinase D1-dependent phosphorylation of dopamine D1 receptor regulates cocaine-induced behavioral responses[J]. Neuropsychopharmacology, 2014, 39(5): 1290-1301. doi: 10.1038/npp.2013.341
|
[14] |
LIU C, KE P, ZHANG JJ, et al. Protein kinase inhibitor peptide as a tool to specifically inhibit protein kinase A[J]. Front Physiol, 2020, 11: 574030.
|
[15] |
PANDALANENI S, KARUPPIAH V, SALEEM M, et al. Neuronal calcium sensor-1 binds the D2 dopamine receptor and G-protein-coupled receptor kinase 1 (GRK1) peptides using different modes of interactions[J]. J Biol Chem, 2015, 290(30): 18744-18756.
|
[16] |
GUPTA MK, MOHAN ML, NAGA PRASAD SV. G protein-coupled receptor resensitization paradigms[J]. Int Rev Cell Mol Biol, 2018, 339: 63-91.
|
[17] |
BURNS JA, KROLL DS, FELDMAN DE, et al. Molecular imaging of opioid and dopamine systems: Insights into the pharmacogenetics of opioid use disorders[J]. Front Psychiatry, 2019, 10: 626.
|
[18] |
CLIFTON NE, TRENT S, THOMAS KL, et al. Regulation and function of activity-dependent Homer in synaptic plasticity[J]. Mol Neuropsychiatry, 2019, 5(3): 147-161.
|